Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of CVS Health Corp (NYSE: CVS) closed at $76.53 in the last session, up 1.19% from day before closing price of $75.63. In other words, the price has increased by $1.19 from its previous closing price. On the day, 8.16 million shares were traded. CVS stock price reached its highest trading level at $76.945 during the session, while it also had its lowest trading level at $75.0.
Ratios:
We take a closer look at CVS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.61 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.44. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.83. In the meantime, Its Debt-to-Equity ratio is 1.12 whereas as Long-Term Debt/Eq ratio is at 1.02.
Upgrades & Downgrades
In the most recent recommendation for this company, Goldman on October 14, 2025, initiated with a Buy rating and assigned the stock a target price of $91.
On August 18, 2025, UBS Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $79.
Robert W. Baird Upgraded its Neutral to Outperform on August 14, 2025, while the target price for the stock was maintained at $82.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 20 ’25 when Finucane Anne A. sold 7,500 shares for $71.02 per share. The transaction valued at 532,650 led to the insider holds 22,156 shares of the business.
Finucane Anne A. bought 7,500 shares of CVS for $532,275 on Aug 20 ’25. On Jun 05 ’25, another insider, SANSONE GUY P, who serves as the Director of the company, bought 1,570 shares for $63.70 each. As a result, the insider paid 100,009 and bolstered with 12,007 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVS now has a Market Capitalization of 97149665280 and an Enterprise Value of 167851671552. As of this moment, CVS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 199.97, and their Forward P/E ratio for the next fiscal year is 10.67. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 13.73. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25 while its Price-to-Book (P/B) ratio in mrq is 1.33. Its current Enterprise Value per Revenue stands at 0.429 whereas that against EBITDA is 11.377.
Stock Price History:
The Beta on a monthly basis for CVS is 0.49, which has changed by 0.37135088 over the last 52 weeks, in comparison to a change of 0.13844287 over the same period for the S&P500. Over the past 52 weeks, CVS has reached a high of $85.15, while it has fallen to a 52-week low of $43.56. The 50-Day Moving Average of the stock is -2.71%, while the 200-Day Moving Average is calculated to be 9.73%.
Shares Statistics:
According to the various share statistics, CVS traded on average about 7.56M shares per day over the past 3-months and 7059750 shares per day over the past 10 days. A total of 1.27B shares are outstanding, with a floating share count of 1.27B. Insiders hold about 0.15% of the company’s shares, while institutions hold 89.03% stake in the company. Shares short for CVS as of 1763078400 were 19288799 with a Short Ratio of 2.55, compared to 1760486400 on 19523681. Therefore, it implies a Short% of Shares Outstanding of 19288799 and a Short% of Float of 1.54.
Dividends & Splits
The forward annual dividend rate for CVS is 2.66, which was 2.66 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.03517123. The stock’s 5-year Average Dividend Yield is 3.16. The current Payout Ratio is 72.76% for CVS, which recently paid a dividend on 2025-10-23 with an ex-dividend date of 2025-10-23. Stock splits for the company last occurred on 2005-06-07 when the company split stock in a 2:1 ratio.
Earnings Estimates
Investors are keenly observing as 23.0 analysts analyze and rate. The current performance of CVS Health Corp (CVS) in the stock market.The consensus estimate for the next quarter is $2.36, with high estimates of $2.61 and low estimates of $2.1.
Analysts are recommending an EPS of between $6.7 and $6.34 for the fiscal current year, implying an average EPS of $6.6. EPS for the following year is $7.16, with 29.0 analysts recommending between $7.5 and $6.74.
Revenue Estimates
According to 17 analysts,. The current quarter’s revenue is expected to be $102.8B. It ranges from a high estimate of $107.53B to a low estimate of $101.31B. As of. The current estimate, CVS Health Corp’s year-ago sales were $97.71BFor the next quarter, 17 analysts are estimating revenue of $99.85B. There is a high estimate of $101.52B for the next quarter, whereas the lowest estimate is $98.02B.
A total of 21 analysts have provided revenue estimates for CVS’s current fiscal year. The highest revenue estimate was $403.9B, while the lowest revenue estimate was $397.59B, resulting in an average revenue estimate of $399B. In the same quarter a year ago, actual revenue was $372.81BBased on 23 analysts’ estimates, the company’s revenue will be $418.33B in the next fiscal year. The high estimate is $437.63B and the low estimate is $391.95B.
